Drug:
Reaction: HEADACHE
20260101 - 20261231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 26555312 |
US |
2 | |
Myocardial infarction, Diabetes mellitus, Blood glucose increased, Nasopharyngitis, Throat irritation, Cough, Headache, Visual impairment, |
||||
INCLISIRAN, |
||||
| 2 | 26555328 |
RU |
42 | |
Hypertensive crisis, Intracranial pressure increased, Asthenia, Headache, Ear discomfort, Malaise, Tinnitus, Blood pressure decreased, |
||||
| 3 | 26555455 |
US |
49 | 1 |
Gout, Transaminases increased, Headache, Electrocardiogram QT prolonged, |
||||
ARSENIC, ARSENIC, |
||||
| 4 | 26555487 |
US |
42 | 2 |
Off label use, Asthenia, Headache, Dizziness, Pyrexia, Swelling face, Off label use, |
||||
BOTULINUM TOXIN TYPE A, BOTULINUM TOXIN TYPE A, BOTULINUM TOXIN TYPE A, BOTULINUM TOXIN TYPE A, |
||||
| 5 | 26555518 |
US |
55 | 2 |
Feeling abnormal, Tremor, Pain, Headache, Neuropathy peripheral, Contusion, Peroneal nerve palsy, Muscle spasms, Fall, |
||||
DIROXIMEL FUMARATE, |
||||
| 6 | 26555535 |
GB |
67 | 2 |
Headache, Dyspepsia, Agitation, Mood altered, Depressed mood, Medication error, Poor quality sleep, Anxiety, Irritability, |
||||
OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 7 | 26555582 |
US |
39 | |
Anxiety, Headache, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 8 | 26555587 |
US |
||
Visual impairment, Headache, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 9 | 26555639 |
US |
53 | |
Headache, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 10 | 26555744 |
US |
48 | 2 |
Infusion site erythema, Infusion site warmth, Headache, Nausea, Fatigue, Off label use, |
||||
DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 11 | 26555758 |
47 | 1 | |
Hypoaesthesia, Headache, Chest pain, Dyspnoea, Heart rate increased, |
||||
TIRZEPATIDE, |
||||
| 12 | 26555887 |
US |
68 | |
Drug ineffective, Off label use, Headache, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 13 | 26555890 |
PE |
62 | 2 |
Brain neoplasm, Headache, |
||||
OLAPARIB, |
||||
| 14 | 26555902 |
US |
37 | |
Disturbance in attention, Dyspnoea, Migraine, Hypoaesthesia, Asthenia, Headache, Malaise, Dizziness, Discomfort, Anxiety, Drug ineffective, Incorrect route of product administration, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 15 | 26555905 |
US |
||
Periorbital oedema, Headache, Head discomfort, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 16 | 26556169 |
US |
2 | |
Headache, Product use complaint, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, FUROSEMIDE, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, ERGOCALCIFEROL, PANTOPRAZOLE SODIUM, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, NEBIVOLOL, NEBIVOLOL HYDROCHLORIDE, TADALAFIL, ALBUTEROL SULFATE, MONTELUKAST SODIUM, MONTELUKAST, SPIRONOLACTONE, OXYGEN, 0XYGEN, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, ESCITALOPRAM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ROSUVASTATIN CALCIUM, LEVOCETIRIZINE DIHYDROCHLORIDE, |
||||
| 17 | 26556249 |
US |
45 | |
Swelling, Eye pain, Headache, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 18 | 26556253 |
US |
49 | |
Hypertension, Headache, |
||||
SELADELPAR LYSINE, |
||||
| 19 | 26556295 |
US |
35 | 2 |
Headache, Fatigue, Nausea, Vomiting, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 20 | 26556302 |
US |
56 | 2 |
Pain, Pyrexia, Headache, Brain fog, Sluggishness, Lethargy, |
||||
TIRZEPATIDE, |
||||
| 21 | 26556347 |
US |
30 | |
Headache, Paraesthesia, Burning sensation, Vision blurred, Hypoaesthesia, Urinary incontinence, Nausea, Dry mouth, Dysphagia, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 22 | 26556348 |
US |
||
Swelling, Headache, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 23 | 26556350 |
US |
||
Headache, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 24 | 26556437 |
US |
68 | 2 |
Headache, Drug titration error, Dizziness, Nausea, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 25 | 26556463 |
CA |
47 | |
Death, Hypoaesthesia, Mobility decreased, Myalgia, Headache, |
||||
AMBRISENTAN, AMBRISENTAN, TADALAFIL, |
||||
| 26 | 26556486 |
CA |
40 | 2 |
Abdominal distension, Adverse reaction, Back injury, Bursitis, Coeliac disease, Condition aggravated, Dyspepsia, Fall, Finger deformity, Folliculitis, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, Grip strength decreased, Headache, Hepatitis, Hypoaesthesia, Injury, Insomnia, Intentional product use issue, Liver function test increased, Malaise, Mobility decreased, Muscular weakness, Musculoskeletal stiffness, Nail disorder, Neck pain, Off label use, Pain in extremity, Pneumonia, Product label confusion, Weight increased, Wheezing, Wound infection, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, |
||||
| 27 | 26556498 |
US |
47 | |
Dizziness, Headache, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 28 | 26556582 |
US |
43 | 1 |
Headache, |
||||
TIRZEPATIDE, |
||||
| 29 | 26556599 |
US |
||
Headache, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 30 | 26556615 |
GB |
53 | |
Headache, Superficial vein prominence, Injection site bruising, Off label use, |
||||
BOTULINUM TOXIN TYPE A, BOTULINUM TOXIN TYPE A, |
||||
| 31 | 26556662 |
US |
61 | |
Headache, Dysphagia, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 32 | 26556688 |
CA |
63 | 2 |
Alopecia, Application site reaction, Chronic spontaneous urticaria, Depression, Dyspnoea, Dyspnoea exertional, Haemorrhage, Headache, Hepatic enzyme increased, Urticaria, Tachycardia, Insomnia, Intervertebral disc protrusion, Malaise, Middle insomnia, Muscular weakness, Pain, Paraesthesia, Primary biliary cholangitis, Pruritus, Scratch, Skin burning sensation, Skin lesion, Skin plaque, Spinal meningeal cyst, Stress, Erythema, Product dose omission issue, Drug ineffective, Incorrect dose administered, Inappropriate schedule of product administration, Wrong technique in product usage process, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, NICOTINE, NICOTINE POLACRILEX, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, |
||||
| 33 | 26556846 |
US |
72 | 1 |
Loss of consciousness, Headache, |
||||
DUPILUMAB, |
||||
| 34 | 26556870 |
US |
||
Incorrect dose administered, Headache, Product use issue, |
||||
ACALABRUTINIB, |
||||
| 35 | 26556885 |
US |
2 | |
Headache, Fatigue, Paraesthesia, |
||||
GUSELKUMAB, |
||||
| 36 | 26557105 |
US |
11 | 1 |
Suicidal ideation, Mood swings, Hunger, Thirst, Pollakiuria, Anxiety, Condition aggravated, Nausea, Vomiting, Diarrhoea, Headache, Malaise, |
||||
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, METHYLPHENIDATE, METHYLPHENIDATE HYDROCHLORIDE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, CETIRIZINE HYDROCHLORIDE, |
||||
| 37 | 26557196 |
EU |
70 | 2 |
Urosepsis, Klebsiella infection, Escherichia infection, Multiple-drug resistance, Cerebral toxoplasmosis, Hemiparesis, Mood altered, Headache, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, CYCLOSPORINE, PREDNISONE, |
||||
| 38 | 26557262 |
US |
||
Cardiac flutter, Diarrhoea, Headache, Fatigue, Dry skin, |
||||
LENALIDOMIDE, LENALIDOMIDE, |
||||
| 39 | 26557264 |
GB |
||
Headache, Diarrhoea, Sleep disorder, Fatigue, Abdominal pain upper, Memory impairment, Dysgeusia, Thirst, |
||||
DAPAGLIFLOZIN, CANDESARTAN, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ROSUVASTATIN, SEMAGLUTIDE, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, |
||||
| 40 | 26557299 |
US |
1 | |
Headache, Dyspnoea, |
||||
SULFUR HEXAFLUORIDE, SULFUR HEXAFLUORIDE, SULFUR HEXAFLUORIDE, |
||||
| 41 | 26557352 |
US |
33 | 1 |
Crohn^s disease, Impaired quality of life, Abdominal pain, Upper respiratory tract infection, Arthralgia, Headache, Fatigue, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, ALLOPURINOL, PREDNISONE, OMEPRAZOLE MAGNESIUM, |
||||
| 42 | 26557355 |
US |
||
Headache, Dyspnoea, Intraocular pressure increased, |
||||
AFLIBERCEPT, |
||||
| 43 | 26557359 |
EU |
79 | 2 |
Cataract, Nausea, Vomiting, Headache, Bone pain, Eye pain, |
||||
POMALIDOMIDE, BELANTAMAB MAFODOTIN, |
||||
| 44 | 26557360 |
US |
||
Gastrooesophageal reflux disease, Headache, Diarrhoea, |
||||
ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE, ESOMEPRAZOLE MAGNESIUM DIHYDRATE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, |
||||
| 45 | 26557396 |
US |
74 | 2 |
Vision blurred, Nausea, Headache, |
||||
RILZABRUTINIB, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, EPINEPHRINE, FLUTICASONE PROPIONATE, FLUCONAZOLE, INSULIN ASPART, NYSTATIN, NYSTATIN OINTMENT, NYSTATIN CREAM, PREDNISONE, INSULIN GLARGINE, |
||||
| 46 | 26557397 |
US |
50 | 2 |
Loss of personal independence in daily activities, Dyspnoea, Headache, Product dose omission in error, |
||||
DUPILUMAB, |
||||
| 47 | 26557405 |
US |
52 | 2 |
Hypertension, Headache, Photophobia, Off label use, |
||||
| 48 | 26557475 |
US |
56 | 2 |
Drug-induced liver injury, Headache, Nausea, Vomiting, Dizziness, |
||||
ABALOPARATIDE, ABALOPARATIDE, ARIPIPRAZOLE, LUMATEPERONE, |
||||
| 49 | 26557481 |
CA |
41 | 2 |
Ileal stenosis, Weight decreased, Constipation, Rash, Urinary tract infection, Headache, Skin mass, Fatigue, Pain of skin, Rash erythematous, |
||||
RISANKIZUMAB-RZAA, |
||||
| 50 | 26557563 |
US |
2 | |
Headache, Back pain, Incorrect dose administered, |
||||
DUPILUMAB, |
||||
| 51 | 26557670 |
IN |
||
Migraine, Headache, Dyspnoea, Multiple sclerosis relapse, |
||||
OCRELIZUMAB, |
||||
| 52 | 26557706 |
57 | 2 | |
Seizure, Muscular weakness, Dizziness, Taste disorder, Mobility decreased, Injection site pain, Headache, Decreased appetite, Mouth injury, Feeding disorder, |
||||
FAM-TRASTUZUMAB DERUXTECAN-NXKI, |
||||
| 53 | 26557720 |
CA |
1 | |
Hemiparesis, Headache, |
||||
VEDOLIZUMAB, |
||||
| 54 | 26557845 |
CA |
54 | 2 |
Neuropathy peripheral, Weight decreased, Headache, Chest pain, Pericardial effusion, Blood glucose increased, Thyroid disorder, Eye haemorrhage, Multi-organ disorder, Myalgia, Abdominal pain upper, Cardiac failure congestive, Pulmonary oedema, Arthritis, Malnutrition, Diarrhoea, |
||||
ESOMEPRAZOLE MAGNESIUM, FLUTICASONE FUROATE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, FLUTICASONE PROPIONATE, INSULIN HUMAN, INSULIN GLARGINE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, INSULIN LISPRO, INSULIN GLARGINE, INSULIN GLARGINE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, LOSARTAN, LOSARTAN, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, SALMETEROL XINAFOATE, VALSARTAN, VALSARTAN ORAL, VALSARTAN, VALSARTAN ORAL, VALSARTAN, VALSARTAN ORAL, |
||||
| 55 | 26557887 |
US |
85 | |
Headache, Inappropriate schedule of product administration, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 56 | 26557917 |
GB |
37 | 2 |
Medication error, Anxiety, Heart rate increased, Headache, Tremor, |
||||
CLARITHROMYCIN, LISDEXAMFETAMINE DIMESYLATE, LISDEXAMFETAMINE, LISDEXAMFETAMINE DIMESYLATE CAPSULES, |
||||
| 57 | 26557939 |
US |
47 | 2 |
Sneezing, Nasal congestion, Headache, Lacrimation increased, Dyspnoea, |
||||
TIRZEPATIDE, |
||||
| 58 | 26558015 |
US |
||
Headache, Nausea, Therapeutic response changed, Product substitution issue, |
||||
DULOXETINE HYDROCHLORIDE, DULOXETINE, |
||||
| 59 | 26558170 |
US |
2 | |
Metabolic dysfunction-associated steatohepatitis, Weight increased, Fluid retention, Headache, Heart rate decreased, Dyspepsia, Epistaxis, Irritable bowel syndrome, |
||||
LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, SEMAGLUTIDE, |
||||
| 60 | 26558320 |
US |
46 | |
Headache, |
||||
AVATROMBOPAG MALEATE, |
||||
| 61 | 26558367 |
US |
2 | |
Crohn^s disease, Headache, |
||||
VEDOLIZUMAB, |
||||
| 62 | 26558487 |
US |
||
Pharyngeal swelling, Chest discomfort, Dyspnoea, Nasal congestion, Fatigue, Urticaria, Nausea, Headache, |
||||
C1 ESTERASE INHIBITOR RECOMBINANT, EPINEPHRINE, ADRENALINUM, LEVOCETIRIZINE DIHYDROCHLORIDE, PYRIDOSTIGMINE BROMIDE, FAMOTIDINE, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, PREDNISONE, KETOTIFEN FUMARATE, BUDESONIDE, LISDEXAMFETAMINE DIMESYLATE, LISDEXAMFETAMINE, LISDEXAMFETAMINE DIMESYLATE CAPSULES, VARENICLINE, VORTIOXETINE, CYCLOSPORINE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, LEVALBUTEROL TARTRATE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, MEPOLIZUMAB, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, ICATIBANT, LEVALBUTEROL HYDROCHLORIDE, LANADELUMAB-FLYO, |
||||
| 63 | 26558608 |
US |
81 | 2 |
Chills, Tremor, Headache, Pyrexia, Palpitations, |
||||
REGADENOSON, LISINOPRIL, |
||||
| 64 | 26558627 |
EU |
||
Sensory disturbance, Pain in extremity, Intraocular pressure increased, Craniocerebral injury, Headache, Nausea, Vomiting, Fall, Rib fracture, Blindness, Balance disorder, Muscular weakness, |
||||
VUTRISIRAN, |
||||
| 65 | 26558712 |
US |
35 | |
Headache, Product use issue, Influenza, |
||||
ISOTRETINOIN, |
||||
| 66 | 26558746 |
CA |
41 | |
Blood pressure increased, Condition aggravated, Nasal congestion, Erythema, Cough, Hot flush, Gingivitis, Ear infection, Influenza, Headache, Arthralgia, Gastroenteritis, Therapeutic product effect decreased, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, LORAZEPAM, OXYBUTYNIN, VALACYCLOVIR HYDROCHLORIDE, LISDEXAMFETAMINE DIMESYLATE, |
||||
| 67 | 26558811 |
US |
56 | 1 |
Headache, Dry skin, Rash, Pruritus, |
||||
TRALOKINUMAB-LDRM, |
||||
| 68 | 26559075 |
CN |
63 | 2 |
Headache, |
||||
FLUVOXAMINE MALEATE, |
||||
| 69 | 26559083 |
GB |
53 | 1 |
Alcohol poisoning, Accidental overdose, Abdominal discomfort, Burns second degree, Cardiac murmur, Catarrh, Cerebrovascular accident, Confusional state, Drug ineffective, Depression, Dysgeusia, Fatigue, Eczema, Frequent bowel movements, Gingival pain, Haematochezia, Hypopnoea, Inappropriate schedule of product administration, Migraine, Headache, Nightmare, Off label use, Pain, Pain in extremity, Palpitations, Parosmia, Pulmonary embolism, Pyrexia, Rash, Rectal haemorrhage, Rhinitis, Somnolence, Steroid dependence, Stress, Swollen tongue, Systemic lupus erythematosus, Tinnitus, Tubulointerstitial nephritis, Vertigo, Weight decreased, Impaired quality of life, Loss of personal independence in daily activities, Impaired work ability, Medication error, Product use in unapproved indication, Intentional product use issue, |
||||
CANDESARTAN CILEXETIL, LATANOPROST, FESOTERODINE FUMARATE, BUDESONIDE, FELODIPINE, FELODIPINE EXTENDED-RELEASE TABLETS, ROSUVASTATIN, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, DAPAGLIFLOZIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ROSUVASTATIN, HYDROCORTISONE ACETATE, HYDROCORTISONE, VEDOLIZUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, OXYCODONE, ERGOCALCIFEROL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, LISDEXAMFETAMINE DIMESYLATE, LISDEXAMFETAMINE, LISDEXAMFETAMINE DIMESYLATE CAPSULES, WARFARIN SODIUM, WARFARIN, VEDOLIZUMAB, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, FUROSEMIDE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ADALIMUMAB, INFLIXIMAB-DYYB, LISDEXAMFETAMINE DIMESYLATE, LISDEXAMFETAMINE, LISDEXAMFETAMINE DIMESYLATE CAPSULES, DESOXIMETASONE, ACETAMINOPHEN, DEXTROMETHORPHAN HBR, ACETAMINOPHEN AND DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN AND PHENYLEPRINE HCL, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR, PRAVASTATIN SODIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, RAMIPRIL, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ESOMEPRAZOLE MAGNESIUM, AMLODIPINE BESYLATE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, DORZOLAMIDE HYDROCHLORIDE, DORZOLAMIDE, RIVAROXABAN, METHOTREXATE, METHOTREXATE SODIUM, TAMSULOSIN HYDROCHLORIDE, FOLIC ACID, TOFACITINIB, BISOPROLOL FUMARATE, EMPAGLIFLOZIN, LANSOPRAZOLE, NITROFURANTOIN, NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE, PREGABALIN, LATANOPROST, MINERAL OIL, NAPHAZOLINE HYDROCHLORIDE, TETRAHYDROZOLINE HYDROCHLORIDE, CAFFEINE, CALCIUM CHLORIDE INJECTION, CALCIUM CHLORIDE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, CALCIUM CARBONATE, ANTACID, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, FELODIPINE, FELODIPINE EXTENDED-RELEASE TABLETS, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, DAPAGLIFLOZIN, LATANOPROST, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, ROSUVASTATIN, ROSUVASTATIN, HYDROCORTISONE ACETATE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, ROSUVASTATIN, ROSUVASTATIN, ROSUVASTATIN, ROSUVASTATIN, ROSUVASTATIN, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, DESOXIMETASONE, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, ADALIMUMAB, ADALIMUMAB, VEDOLIZUMAB, WARFARIN SODIUM, WARFARIN, OXYCODONE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, ROSUVASTATIN, |
||||
| 70 | 26559141 |
GB |
34 | 1 |
Angina pectoris, Dizziness, Arthralgia, Muscle spasms, Muscular weakness, Hypoaesthesia, Balance disorder, Headache, Eye pain, |
||||
OFATUMUMAB, |
||||
| 71 | 26559152 |
US |
2 | |
Urine output decreased, Decreased appetite, Pain, Pruritus, Headache, Peripheral swelling, Peripheral swelling, Joint swelling, Infusion site discharge, |
||||
| 72 | 26559157 |
2 | ||
Headache, Bone density decreased, |
||||
REPOSITORY CORTICOTROPIN, REPOSITORY CORTICOTROPIN, |
||||
| 73 | 26559204 |
66 | 2 | |
Headache, |
||||
REPOSITORY CORTICOTROPIN, REPOSITORY CORTICOTROPIN, |
||||
| 74 | 26559230 |
CA |
45 | 2 |
Abdominal discomfort, Arthralgia, Autoimmune disorder, Blood cholesterol increased, Confusional state, Contusion, Decreased appetite, Deep vein thrombosis postoperative, Drug ineffective, Eye injury, Folliculitis, Gait inability, Gastrointestinal disorder, Headache, Helicobacter infection, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Incorrect route of product administration, Infection, Irritable bowel syndrome, Liver disorder, Lower respiratory tract infection, Lupus vulgaris, Maternal exposure during pregnancy, Muscle injury, Musculoskeletal stiffness, Nasopharyngitis, Nausea, Pemphigus, Peripheral swelling, Off label use, Pruritus, Rash, Rheumatic fever, Rheumatoid factor positive, Swelling, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Vomiting, Wheezing, Wound, |
||||
TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, RITUXIMAB, |
||||
| 75 | 26559305 |
EU |
83 | |
Vasoplegia syndrome, Vertigo, Tremor, Bradycardia, Bradycardia, Hypotension, Headache, Nausea, Chills, Tremor, Headache, Nausea, Chills, Dizziness, Device issue, |
||||
DEGARELIX, DEGARELIX, DEGARELIX, DEGARELIX, ALLOPURINOL, FUROSEMIDE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, CANDESARTAN, ENZALUTAMIDE, |
||||
| 76 | 26559339 |
US |
38 | |
Drug intolerance, Disorientation, Dizziness, Headache, Product use in unapproved indication, |
||||
DOXYCYCLINE, DOXYCYCLINE HYCLATE, |
||||
| 77 | 26559397 |
IL |
56 | 2 |
Rectal haemorrhage, Asthenia, Epistaxis, Haemoglobin increased, Headache, Dizziness, Gingival bleeding, Injection site pruritus, Feeling hot, Sinusitis, Haemoglobin abnormal, Gingival swelling, Gingival pain, Asthenia, Gingival swelling, Gingival pain, |
||||
SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, |
||||
| 78 | 26559411 |
2 | ||
Encephalitis, Nuchal rigidity, Photophobia, Headache, |
||||
| 79 | 26559484 |
GB |
27 | |
Loss of consciousness, Vision blurred, Headache, Nausea, Product dose omission in error, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 80 | 26559494 |
46 | ||
Headache, |
||||
BIMEKIZUMAB, |
||||
| 81 | 26559519 |
US |
58 | 1 |
Headache, Device malfunction, Product storage error, |
||||
FREMANEZUMAB-VFRM, |
||||
| 82 | 26559525 |
US |
25 | 2 |
Neoplasm progression, Serotonin syndrome, Hypoaesthesia, Flat affect, Affective disorder, Oropharyngeal pain, Abdominal distension, COVID-19, Pain in extremity, Muscle spasms, Withdrawal syndrome, Headache, Dizziness, Asthenia, Tremor, Vomiting, Fatigue, Treatment noncompliance, |
||||
FLUOXETINE HYDROCHLORIDE, NIROGACESTAT, NIROGACESTAT, LORAZEPAM, |
||||
| 83 | 26559554 |
AU |
2 | |
Cataract, Brain fog, Memory impairment, Vitreous floaters, Dry eye, Headache, Abdominal distension, Weight increased, Feeling of despair, Depressed mood, Mental disorder, |
||||
TOFACITINIB, UPADACITINIB, |
||||
| 84 | 26559613 |
US |
71 | 2 |
Mobility decreased, Asthenia, Illness, Gastrointestinal disorder, Headache, Nausea, |
||||
SEMAGLUTIDE, |
||||
| 85 | 26559638 |
US |
||
Restless legs syndrome, Energy increased, Discomfort, Nausea, Headache, |
||||
PROMETHAZINE HYDROCHLORIDE, |
||||
| 86 | 26559642 |
US |
68 | 2 |
Headache, |
||||
TIRZEPATIDE, |
||||
| 87 | 26559689 |
US |
46 | 2 |
Cerebrovascular accident, Myocardial infarction, Headache, Drug ineffective, |
||||
ERENUMAB-AOOE, ERENUMAB-AOOE, DIPHENHYDRAMINE HYDROCHLORIDE, UBROGEPANT, |
||||
| 88 | 26559730 |
US |
72 | |
Pneumonia, Haemoptysis, Lethargy, Oedema peripheral, Peripheral swelling, Contusion, Nail discolouration, Product distribution issue, Dyspnoea exertional, Product dose omission issue, Headache, Dyspnoea, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, |
||||
| 89 | 26559910 |
US |
47 | 2 |
Cardiac murmur, Fatigue, Headache, |
||||
AVAPRITINIB, |
||||
| 90 | 26559946 |
TR |
2 | |
Headache, Dyspnoea, |
||||
ECULIZUMAB, ECULIZUMAB, |
||||
| 91 | 26559948 |
US |
2 | |
Pyrexia, Asthenia, Gait disturbance, Headache, |
||||
OFATUMUMAB, |
||||
| 92 | 26559952 |
CA |
40 | 2 |
Blepharospasm, Bursitis, C-reactive protein increased, Decreased appetite, Depression, Diarrhoea, Discomfort, Dizziness, Duodenal ulcer perforation, Epilepsy, General physical health deterioration, Grip strength decreased, Hand deformity, Headache, Live birth, Hepatic enzyme increased, Hypoaesthesia, Inflammation, Infusion related reaction, Joint swelling, Type 2 diabetes mellitus, |
||||
SECUKINUMAB, DICLOFENAC SODIUM, CANDESARTAN, LEFLUNOMIDE, MAGNESIUM, RITUXIMAB, ERENUMAB-AOOE, OXYCODONE HYDROCHLORIDE, OXYCODONE, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ERENUMAB-AOOE, DICLOFENAC, DICLOFENAC SODIUM, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, DICLOFENAC SODIUM, |
||||
| 93 | 26560133 |
US |
||
Headache, |
||||
TIRZEPATIDE, |
||||
| 94 | 26560138 |
US |
76 | 2 |
Amyloid related imaging abnormality-microhaemorrhages and haemosiderin deposits, Amyloid related imaging abnormality-oedema/effusion, Cerebral haemorrhage, Migraine, Migraine, Vision blurred, Photopsia, Sleep disorder, Headache, Off label use, |
||||
ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, CAFFEINE, PREDNISONE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 95 | 26560140 |
US |
78 | 1 |
Amyloid related imaging abnormality-microhaemorrhages and haemosiderin deposits, Brain oedema, Aphasia, White matter lesion, Nasal septum deviation, Confusional state, Headache, |
||||
DONANEMAB-AZBT, DONANEMAB-AZBT, DONANEMAB-AZBT, |
||||
| 96 | 26560235 |
US |
33 | 2 |
Headache, Sleep disorder due to a general medical condition, |
||||
DUPILUMAB, FAMOTIDINE, METHOTREXATE, METHOTREXATE SODIUM, MONTELUKAST SODIUM, MONTELUKAST, NIFEDIPINE, ABATACEPT, DROSPIRENONE, |
||||
| 97 | 26560340 |
US |
3 | 1 |
Headache, |
||||
DUPILUMAB, |
||||
| 98 | 26560396 |
US |
78 | 2 |
Headache, Eye disorder, |
||||
DUPILUMAB, |
||||
| 99 | 26560400 |
US |
55 | 2 |
Pain in extremity, Headache, Locomotive syndrome, Rest regimen, Arthralgia, Condition aggravated, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 100 | 26560498 |
US |
2 | |
Chronic kidney disease, Anaemia, Chest discomfort, Diarrhoea, Fatigue, Asthenia, Headache, Gastrointestinal disorder, Full blood count abnormal, Pain, Contusion, |
||||
OLAPARIB, OLAPARIB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28